OR WAIT null SECS
January 10, 2023
Eisai’s Alzheimer’s treatment, Leqembi (lecanemab-irmb), received approval from FDA via the Accelerated Approval pathway.
January 09, 2023
Astrea Bioseparations has acquired Delta Precision, a manufacturer of chromatography columns for biomanufacturing.
January 04, 2023
Agilent’s acquisition of Avida grants them access to high-performance enrichment workflows that enable NGS approaches for studying cancer.
Merck, known as MSD outside of the United States and Canada, will pay Kelun-Biotech up to $9l3 billion for seven early-stage oncology treatments.
January 02, 2023
TreeFrog Therapeutics is leaping ahead in cell therapies through resources such as new technologies and investor partnerships.
December 20, 2022
FDA has announced that bebtelovimab is not currently authorized for emergency use in any region of the US.
Sosei Heptares and Eli Lilly have entered a multi-target collaboration and license agreement in diabetes and metabolic diseases.
December 19, 2022
GSK and Wave Life Sciences have entered into a collaboration to drive drug discovery and development for novel genetic targets.
AbCellera and Rallybio are teaming up to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases.
December 16, 2022
Catalent is set to expand its biologics analytical services with its new facility in Durham, NC.